Showing results (81-90 of 196) with videos related to

Sort By:
Pageof 20
Neuropediatrics|October 17, 2024
Management of Critically Ill Children with Acute Necrotizing Encephalitis during an H1N1 Outbreak in a Tertiary Pediatric Hospital: A Series of Three Cases and Literature ReviewAnnalisa D'Eleuterio, Paolo Rufini, Manuela L'Erario, et al.
Lupus|November 25, 2025
Eculizumab as an adjunctive rescue treatment for life-threatening childhood onset of systemic lupus erythematosusAnna Chiara Tiezzi, Linda Zollo, Edoardo Marrani, et al.
Autoimmunity Reviews|January 8, 2024
Childhood mixed connective tissue disease at disease onset: Evidence from a systematic reviewAlberto Terminiello, Edoardo Marrani, Ilaria Pagnini, et al.
Italian Journal of Pediatrics|June 30, 2018
Common symptoms for a rare disease in a girl with sarcoidosis: a case reportMattia Giovannini, Michele Luzzati, Giovanna Ferrara, et al.
Frontiers in Pediatrics|December 22, 2022
Pseudo-rheumatic manifestations of limping: Camptodactyly-arthropathy-coxa vara-pericarditis syndrome: Single case report and review of the literatureValerio Maniscalco, Camilla Pizzetti, Edoardo Marrani, et al.
Clinical and Experimental Rheumatology|April 24, 2010
Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapyBiagio Olivito, Andrea Taddio, Gabriele Simonini, et al.
Frontiers in Pediatrics|May 2, 2022
Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison ExperienceIlaria Maccora, Sarah Abu Rumeileh, Franco Curci, et al.
Expert Opinion on Biological Therapy|May 17, 2023
Anti-IL17 treatment in childhood chronic rheumatic diseasesValerio Maniscalco, Ilaria Maccora, Flavio Girodo, et al.
The Journal of Rheumatology|October 11, 2002
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritisLaura Masi, Rolando Cimaz, Gabriele Simonini, et al.
Pediatric Rheumatology Online Journal|April 17, 2013
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitisGabriele Simonini, Andrea Taddio, Marco Cattalini, et al.
Pageof 20